company background image
603351 logo

Nanjing Well Pharmaceutical GroupLtd XSSC:603351 Stock Report

Last Price

CN¥24.07

Market Cap

CN¥3.3b

7D

-7.3%

1Y

-12.0%

Updated

24 Nov, 2024

Data

Company Financials

Nanjing Well Pharmaceutical Group Co.,Ltd.

XSSC:603351 Stock Report

Market Cap: CN¥3.3b

603351 Stock Overview

Nanjing Well Pharmaceutical Group Co.,Ltd. More details

603351 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends3/6

Rewards

Risk Analysis

No risks detected for 603351 from our risk checks.

Nanjing Well Pharmaceutical Group Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nanjing Well Pharmaceutical GroupLtd
Historical stock prices
Current Share PriceCN¥24.07
52 Week HighCN¥27.73
52 Week LowCN¥17.65
Beta0.41
11 Month Change-6.12%
3 Month Change18.92%
1 Year Change-11.96%
33 Year Change-31.03%
5 Year Change9.44%
Change since IPO-2.86%

Recent News & Updates

Recent updates

Shareholder Returns

603351CN ChemicalsCN Market
7D-7.3%-0.9%-2.1%
1Y-12.0%-5.3%2.8%

Return vs Industry: 603351 underperformed the CN Chemicals industry which returned -5.3% over the past year.

Return vs Market: 603351 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 603351's price volatile compared to industry and market?
603351 volatility
603351 Average Weekly Movement6.7%
Chemicals Industry Average Movement8.0%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 603351 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 603351's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000673Renrong Wuwww.well-js.com

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables.

Nanjing Well Pharmaceutical Group Co.,Ltd. Fundamentals Summary

How do Nanjing Well Pharmaceutical GroupLtd's earnings and revenue compare to its market cap?
603351 fundamental statistics
Market capCN¥3.26b
Earnings (TTM)CN¥146.83m
Revenue (TTM)CN¥1.33b

22.2x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603351 income statement (TTM)
RevenueCN¥1.33b
Cost of RevenueCN¥981.02m
Gross ProfitCN¥346.50m
Other ExpensesCN¥199.68m
EarningsCN¥146.83m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.08
Gross Margin26.10%
Net Profit Margin11.06%
Debt/Equity Ratio25.3%

How did 603351 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

28%

Payout Ratio